Qingdao NovelBeam Technology Co.,Ltd. (SHA:688677)
China · Delayed Price · Currency is CNY 40.89
+0.18 (0.44%)
At close: Mar 6, 2026
SHA:688677 Revenue
In the year 2025, Qingdao NovelBeam Technology had annual revenue of 602.61M CNY with 36.08% growth. Qingdao NovelBeam Technology had revenue of 154.97M in the quarter ending December 31, 2025, with 24.82% growth.
Revenue
602.61M
Revenue Growth
+36.08%
P/S Ratio
8.04
Revenue / Employee
716.54K
Employees
967
Market Cap
4.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 602.61M | 159.78M | 36.08% |
| Dec 31, 2024 | 442.83M | -27.77M | -5.90% |
| Dec 31, 2023 | 470.60M | -6.22M | -1.31% |
| Dec 31, 2022 | 476.82M | 167.15M | 53.97% |
| Dec 31, 2021 | 309.67M | 34.48M | 12.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhonghong Pulin Medical Products | 2.48B |
| Shanghai Kindly Enterprise Development Group Co.,LTD. | 2.28B |
| Well Lead Medical | 1.64B |
| Jiangxi Sanxin Medtec | 1.59B |
| Zhejiang Gongdong Medical Technology | 1.12B |
| Hangzhou Alltest Biotech | 911.30M |
| SWS Hemodialysis Care | 733.59M |
| Chimin Health Management | 637.78M |